Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: November 29, 2021

DrugPatentWatch Database Preview

Patent: 8,865,718

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,865,718
Title:Heterocyclic inhibitors of glutaminase
Abstract: The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.
Inventor(s): Li; Jim (San Francisco, CA), Chen; Lijing (Cupertino, CA), Goyal; Bindu (Fremont, CA), Laidig; Guy (Woodside, CA), Stanton; Timothy Friend (Daly City, CA), Sjogren; Eric Brian (Mountain View, CA)
Assignee: Calithera Biosciences Inc. (South San Francisco, CA)
Application Number:14/051,216
Patent Claims:see list of patent claims

Details for Patent 8,865,718

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 1978-01-10 ⤷  Try it Free 2031-11-21
Organon Teknika Corporation Llc TICE BCG bcg live For Injection 102821 1989-06-21 ⤷  Try it Free 2031-11-21
Amgen, Inc. NEUPOGEN filgrastim Injection 103353 1991-02-20 ⤷  Try it Free 2031-11-21
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.